| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/29/2023 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 41.1k | $1.05 | $43.1k | | 03/29/2023 |
| 09/29/2022 | TFF Pharmaceuticals, Inc. | TFFP | Sale | Common Stock | 40.3k | $4.29 | $172.7k | | 09/29/2022 |
| 09/29/2022 | TFF Pharmaceuticals, Inc. | TFFP | Exercise | Stock Options (Right to Buy) | 40.3k | $2.50 | $100.6k | | 09/29/2022 |
| 03/23/2022 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 81.9k | $1.92 | $157.2k | | 03/23/2022 |
| 05/18/2021 | TFF Pharmaceuticals, Inc. | TFFP | Purchase | Common Stock | 1k | $9.40 | $9.9k | | 05/18/2021 |
| 03/24/2021 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 20.9k | $2.27 | $47.4k | | 03/24/2021 |
| 11/13/2020 | TFF Pharmaceuticals, Inc. | TFFP | Sale | Common Stock | 5k | $17.17 | $85.9k | | 11/11/2020 |
| 11/11/2020 | TFF Pharmaceuticals, Inc. | TFFP | Sale | Common Stock | 34.5k | $15.91 | $548.9k | | 11/11/2020 |
| 11/11/2020 | TFF Pharmaceuticals, Inc. | TFFP | Exercise | Stock Options (Right to Buy) | 34.5k | $2.50 | $86.3k | | 11/11/2020 |
| 10/05/2020 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 396.8k | $0.71 | $279.8k | | 10/01/2020 |
| 10/01/2020 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 259.3k | $0.71 | $184.1k | | 10/01/2020 |
| 09/14/2020 | Outlook Therapeutics, Inc. | ONS | Purchase | Common Stock | 10k | $0.62 | $6.2k | | 09/14/2020 |
| 08/24/2020 | TFF Pharmaceuticals, Inc. | TFFP | Grant | Stock Options (Right to Buy) | 20k | $13.65 | $273k | | 08/24/2020 |
| 07/17/2020 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 154.6k | $1.58 | $244.2k | | 07/17/2020 |
| 07/17/2020 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 210k | $1.58 | $331.8k | | 07/17/2020 |
| 03/19/2020 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 15k | $0.54 | $8.1k | | 03/19/2020 |
| 11/29/2019 | TFF Pharmaceuticals, Inc. | TFFP | Grant | Stock Options (Right to Buy) | 3.6k | $5.00 | $18.1k | | 11/29/2019 |
| 10/29/2019 | TFF Pharmaceuticals, Inc. | TFFP | Grant | Stock Options (Right to Buy) | 43.8k | $5.00 | $219k | | 10/25/2019 |
| 10/25/2019 | TFF Pharmaceuticals, Inc. | TFFP | Purchase | Common Stock | 5k | $5.00 | $25k | | 10/25/2019 |
| 10/03/2019 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 207k | $1.40 | $289.9k | | 10/03/2019 |
| 10/03/2019 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 15k | $1.40 | $21k | | 10/03/2019 |
| 12/21/2018 | Outlook Therapeutics, Inc. | ONS | Purchase | Common Stock | 15k | $0.68 | $10.3k | | 12/21/2018 |
| 11/09/2018 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 567.5k | $0.89 | $505.1k | | 11/09/2018 |
| 09/21/2018 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 15k | $0.92 | $13.7k | | 09/21/2018 |
| 06/27/2018 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 100k | $0.88 | $88k | | 06/27/2018 |
| 04/13/2018 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 25k | $0.92 | $23k | | 04/13/2018 |
| 05/22/2017 | Veradigm Inc. | MDRX | Grant | Common Stock | 16.8k | $0.00 | $0 | | 05/22/2017 |
| 03/13/2017 | Presbia PLC | LENS | Grant | Ordinary Shares | 12.7k | $0.00 | $0 | | 03/13/2017 |
| 03/08/2017 | Presbia PLC | LENS | Exercise (in-the-money or at-the-money) | Subscription Rights (right to buy) | 16.5k | $3.00 | $49.6k | | 03/08/2017 |
| 08/05/2016 | Presbia PLC | LENS | Grant | Ordinary Shares | 8.2k | $0.00 | $0 | | 08/05/2016 |
| 05/24/2016 | Veradigm Inc. | MDRX | Grant | Common Stock | 15.1k | $0.00 | $0 | | 05/24/2016 |
| 03/12/2013 | Veradigm Inc. | MDRX | Purchase | Common Stock | 4k | $12.73 | $50.9k | | 03/12/2013 |
| 05/10/2010 | CardioNet, Inc. | BEAT | Grant | | 34.1k | $0.00 | $0 | | 05/10/2010 |
| 05/10/2010 | CardioNet, Inc. | BEAT | Grant | Stock Option (right to buy) | 47.4k | $8.79 | $416.7k | | 05/10/2010 |